首页 | 本学科首页   官方微博 | 高级检索  
检索        

血必净注射液佐治社区获得性肺炎的疗效及安全性探究
引用本文:王石磊,邢丽华.血必净注射液佐治社区获得性肺炎的疗效及安全性探究[J].中国医药指南,2013(3):8-9.
作者姓名:王石磊  邢丽华
作者单位:郑州大学第一附属医院呼吸重症科,河南郑州450052
摘    要:目的探究血必净注射液在治疗社区获得性肺炎中的疗效及安全性。方法选取120例入住郑州大学第一附属医院呼吸重症医学科社区获得性肺炎成人患者随机分为抗生素对照组、抗生素联合血必净注射液观察组各60例。两组均治疗12d后比较疗效、评价安全性。结果两组总有效率分别为观察组98.33%,对照组86.67%,观察组疗效明显优于对照组,经统计学检验差异有统计学意义。同时观察组与对照组的不良反应发生率差异无统计学意义。均无明显药物不良反应。结论血必净注射液辅助治疗社区获得性肺炎安全有效,辅助抗生素治疗能提高疗效,值得进一步推广应用。

关 键 词:社区获得性肺炎  血必净注射液  抗生素  疗效  安全性

Clinical Effects and Security Research on Treating Community Acquired Pneumonia with Xue Bi Jing Injection
WANG Shi-lei,XING Li-hua.Clinical Effects and Security Research on Treating Community Acquired Pneumonia with Xue Bi Jing Injection[J].Guide of China Medicine,2013(3):8-9.
Authors:WANG Shi-lei  XING Li-hua
Institution:(Department of RICU, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China)
Abstract:Objective Research the clinical effects and security on treating community acquired pneumonia with Xue Bi Jing injection. Methods Selecting 120 cases of community acquired pneumonia patients of the first affiliated hospital of Zhengzhou university, and randomly divided then into treatment group (antibiotics+Xue Bi Jing) and control group (antibiotic group),60 eases in each group. Compared their effective and evaluate their security after treated 12 days separately. Results The effective rate in treatment group and control group were 98.33% and 86.67%,and treatment group obviously better than the control group,in which,the statistically has significantly difference(P〉0.01).It was no obviously difference that the incidence of adverse reaction in treatment group and control group(P〉0.05), and both of the two groups had no significant adverse drug reactions. Conclusion Xue Bi Jing injection treat community acquired pneumonia was effective and safety, which combination with antibiotics could improve efficacy, so it was worth further promoting in clinical application.
Keywords:Community acquired pneumonia  Xue Bi Jing injection  Antibiotic  Efficacy  Security
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号